News Center

Home page

Peak Report

News reports

The company held 2016 annual board of directors, board of supervisors

Release time:

2020-08-14

Company Held 2016 Board of Directors and Board of Supervisors

to Review and Pass the Board's Work Report and Other Proposals and Reports

News 4# November 15 , the 11 Meeting of the 9th Board of Directors of the Group Company was held in Jianfeng Building, deliberated and passed 2016 Board of Directors Work Report, 2016 General Manager Work Report and other 14 proposals and reports. The

meeting was presided over by Jiang Xiaomeng, chairman of the group company. Yu Jianhong, general manager, made an annual work report on behalf of the management team, comprehensively summarizing and reviewing the company's 2016 work.

In 2016 , the company focused on the general policy of "innovation, integration, improvement, and development", actively sought new opportunities for development, made new breakthroughs in cooperative innovation, carried out in-depth management integration, continuously improved management levels, and strengthened marketing Management and market expansion have achieved steady growth in product sales, technological innovation and technological transformation have achieved obvious results, and corporate image and influence have been effectively improved. The company realized operating income of 23.79 .2 billion yuan for the whole year, up 5.34% year on year. Net profit attributable to owners of the parent company 28522.95 yuan, up 41.98% year on year, the highest level in history. By the end of 2016 , the company's total assets were 39.95 .2 billion yuan, up 10% year on year. Net assets were 25.52 .6 billion yuan, up 9.82 year on year.

2016 , thanks to the national strategy of "the belt and road initiative", the national cement production increased by 2.3% year-on-year, driven by the recovery of infrastructure investment and real estate investment. The growth of total demand, the development and construction of the southwest region and the implementation of a series of structural reform measures on the supply side of the cement industry, including peak production, industry self-discipline and market integration, cement prices rebounded after bottoming out in the first half of 2016 , and the cement industry in some areas improved. The company's cement business sector seized the opportunity of supply-side reform, actively advocated industry self-discipline, and worked closely around the cost-leading strategy. Daye Peak actively participated in large-scale project bidding while increasing the expansion of the civil market for bagged cement, striving to maintain the gross profit level of tons of cement and ensuring the balance of production and sales in the off-season market. Yunnan Peak strives to enhance the brand status of Peak Cement and advocates self-discipline in the cement industry in southwest Yunnan, actively develop key projects, continue to expand market share, and significantly improve economic efficiency.

Peak Pharmaceutical strives to seek new projects and make new breakthroughs according to strategic planning. In terms of business development, Jianfeng Pharmaceutical has introduced advanced German technology and established a Sino-German joint venture Zhejiang Jindal Baby Drug Co., Ltd. to build a platform specializing in the research and development, production and operation of infant drugs. After more than half a year of research and negotiation, it successfully reached an agreement with Beihui Biology's major shareholders to take a stake in Beihui Biology by way of capital increase and equity transfer. In terms of equity investment, the company also completed the capital increase of Peak Pharmaceuticals and Tianshili Group. In terms of product sales, efforts have been made to realize the entry of peak pharmaceutical products into various catalogues. Jinhua Pharmaceutical Company has obtained the qualification of main distribution in Yiwu primary hospitals. Peak pharmacy has added 4 chain stores and 4 designated medical insurance pharmacies, realizing sales growth. In terms of technological innovation, the research and development project of Jianfeng Pharmaceutical's new anti-tumor drug DPT (deoxypodophyllotoxin) is progressing smoothly, and it has obtained clinical trial approval documents issued by CFDA and obtained a number of related invention patents.

peak health food extraction workshop passed GMP certification, extraction workshop passed Kosher (clean food), halal (halal) certification, and passed ISO9001 , ISO22000 system on-site audit; Complete the drug production record of Ginkgo biloba extract and the establishment of GMP management system, complete the certification of SC for 5 unit foods such as jelly, flavored tea, plant beverages, etc. Tianjin Jianfeng Natural Products Company has strengthened the development of the domestic market while continuing to expand the international market, realizing the simultaneous growth of international and domestic market sales. Peak cable through the product system, Ter and other certification supervision and inspection, large logarithmic cable successfully entered the Hangzhou G20 project. At the same time, the company takes budget management and benchmarking management as the guidance, fine management and PDCA

cycle management as the method, comprehensively carries out the "three reductions and three improvements" activities with the core of reducing costs, reducing expenses and reducing employment, improving work efficiency, improving marketing ability and improving innovation ability, continuously promoting management improvement and providing guarantee for the further development of the company. The board of directors of

also deliberated and approved the "plan on profit distribution for 2016

" and decided to distribute cash for

2016 , based on 2016 year-end share capital ,344,083, 828 shares, and distribute cash dividend 2.5 yuan (including tax) for every 10 shares, the total amount of cash dividends distributed to all shareholders registered on the date of record is 86,020,957.00 yuan (including tax), and 2016 will not be converted into share capital. The distribution plan still needs to be approved by the general meeting of shareholders. If it is implemented, the cash dividend accumulated by the company to shareholders in the last three years will reach 23397.70 .14 million yuan. On the same day, 115 , the company also held the 119 meeting of the 10th 118 of the 8th board of supervisors, deliberated and passed the 123 proposals and reports of the 5th board of supervisors of the company 2016 and the proposal on adding supervisors. (Zhou Hengbin)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页